Vaccine | Route of administration | Log10CFU/spleen (mean ± SE) | Log10protection | *Value (P) |
---|---|---|---|---|
Monovalent Flu-NS1-124-Omp 16 (H5 + H1) | i.n. | 2.0 ± 0.52 | 2.54 | <0.01 |
c. | 0.76 ± 0.44 | 3.78 | <0.001 | |
s.c. | 1.26 ± 0.52 | 3.28 | <0.005 | |
Monovalent Flu-NS1-124-L7L12 (H5 + H1) | i.n. | 1.22 ± 0.50 | 3.32 | <0.001 |
c. | 2.4 ± 0.25 | 2.14 | <0.005 | |
s.c. | 1.46 ± 0.39 | 3.08 | <0.001 | |
Bivalent vaccine formulation Flu-NS1-124-Omp 16 + Flu-NS1-124-L7L12 (H5 + H1) | i.n. | 1.28 ± 0.52 | 3.26 | <0.005 |
c. | 0.64 ± 0.40 | 3.90 | <0.001 | |
s.c. | 1.68 ± 0.51 | 2.86 | <0.005 | |
B. abortus 19 | s.c. | 0.42 ± 0.26 | 4.12 | <0.001 |
Control (PBS) | s.c. | 4.54 ± 0.43 | 0.00 |